Atlas Trials

I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD

Clinical trial NCT02874820 · TERMINATED

Trial details

NCT number
NCT02874820
Sponsor
Imperial College London
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2016-07-01
Primary completion
2017-03-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.